AstraZeneca

Most recent

• FTSE slumps by nearly 3% but Royal Mail bucks falling trend

  15 Oct 2014: Postal business benefits from positive broker reaction to Paddington property sale

• FTSE 100 slumps on Shire deal doubts but airlines rise on falling oil price

  15 Oct 2014: International Airlines Group and easyJet lead risers but healthcare drags market down

• FTSE slumps another 1.4% with chipmakers hit by Microchip warning

  10 Oct 2014: Investors move out of shares again as economy and Ebola fears continue

• BAE Systems slides after downgrade

  7 Oct 2014: Cantor Fitzgerald says company moving to period of calm but cuts from buy to hold

• Rebuffed AstraZeneca suitor ‘likely to return’

  26 Sep 2014: Pfizer’s £69bn takeover bid undervalued UK drug firm’s prospects, says Neil Woodford, as he anticipates fresh offer

• FTSE suffers biggest one day fall since March but Carnival cruises higher

  23 Sep 2014: Investors unnerved by poor eurozone data, Syrian air strikes and supermarkets

• AstraZeneca shares fall as Obama thwarts tax inversion deals

  23 Sep 2014: Pfizer pursuit of UK pharmaceutical less likely after president closes loophole allowing takeovers in lower tax regimes

• FTSE slumps again while Tate & Lyle loses 17% after profit warning

  23 Sep 2014: Poor data, US tax moves and warning from sweetener group unsettle investors

• FTSE dips ahead of Scottish vote and Federal Reserve meeting

  16 Sep 2014: Oil companies BP and Shell climb after crude edges higher again but Asos slumps

• FTSE dips while AstraZeneca falls despite Lilly alzheimer's deal

  16 Sep 2014: Investors continue to be cautious ahead of Scottish vote and Federal Reserve meeting

• As battle over AstraZeneca looms, one lab in Slough shows mergers can work

  31 Aug 2014: The bid from Pfizer, now active again, has caused widespread anger. But another takeover 10 years ago was a different story, writes Julia Kollewe

• FTSE 100 hits seven week high on Draghi QE hints

  26 Aug 2014: Investors hope for more cheap central bank money, as global tensions ease

• Switzerland's Roche agrees to buy US biotech company InterMune

  25 Aug 2014: Multibillion-dollar consolidation of global pharmaceutical sector continues with another blockbuster

• FTSE ends positive week on a downbeat note but Vodafone climbs on bid talk

  22 Aug 2014:

  Apple climbs to another new peak after helping push S&P 500 to a record on Thursday

• FTSE flat ahead of central bankers meeting but bid talk lifts Vodafone and AstraZeneca

  22 Aug 2014: Investors cautious awaiting speeches in US from Federal Reserve and ECB bosses

• Next
• 1
• 2
• 3
• 4
• 5

1-15 of 550 for AstraZeneca